BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

Debiopharm Acquires Global Rights for Novo Nordisk's USP1 Inhibitor Development.

Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow's standard-of-care treatments to cure can...

March 02, 2023 | News

JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma

Primary hepatic cancer is a common malignant tumor of the digestive system worldwide, with high malignancy and hepatic prognosis. As the most common pathol...

March 01, 2023 | News

Gene Solutions' Latest Update: Promising Multi-Cancer Early Detection in Southeast Asia

Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...

March 01, 2023 | News

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer

The clinical trial to be conducted by Peter Mac will be the first time a CAR-T cell therapy product containing the genetic modifications incorporated into ...

February 27, 2023 | News

Biosyngen has obtained FDA IND clearance of BRG01 for Phase I/II clinical trials against Nasopharyngeal Cancer

Prior to this approval from the US FDA, Biosyngen's BRG01 was granted IND by China CDE on December 14th, 2022. In addition, China CDE has acknowledged...

February 18, 2023 | News

Eurofins Discovery Collaborating with Invasight on Cancer Therapies

Invasight is teaming with Eurofins Discovery's DiscoveryOne™, an integrated drug discovery platform that provides expert comprehensive support t...

February 15, 2023 | News

Boan Biotech's Investigational Anti-CD25 Antibody BA1106 Administered for First Patient in Phase I Clinical Trial

BA1106 is the first investigational anti-CD25 antibody to start clinical trials in China for treating solid tumors. Focusing on key therapeutic a...

February 13, 2023 | News

NGeneBio launched NGS based breast cancer diagnostic service in Thailand

Launched NGS based breast cancer diagnostic service in a newly installed inspection laboratory of a Thai consignment inspection agency, MP Group. &n...

February 06, 2023 | News

BeiGene Aim to Accelerate Integration of Mental Health into Quality Cancer Care

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, has released a report highlighting the challenges cancer patients and car...

February 03, 2023 | News

GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer

Combined with other clinical risk factors the test provides a comprehensive risk assessment in a simple saliva test. Highlights: New test integ...

February 03, 2023 | News

TransCure bioServices offers BioVolume 3D imaging for insightful preclinical oncology research

TransCure bioServices adds BioVolume 3D imaging to its service offerings, enabling them to deliver even higher quality tumor growth results to customers. W...

February 02, 2023 | News

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

Based on positive clinical readouts from a Phase IIb study for isSCC and a Phase II study for BCC, Sirnaomics is formulating a communication package for th...

February 02, 2023 | News

Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for Tagrisso

As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-...

January 24, 2023 | News

Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test

The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolutio...

January 23, 2023 | News

Stay Connected